When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Disney posted a surprise $0.08 in earnings per share (EPS) and $11.78 billion in revenue in the second quarter. Analysts were expecting a net loss of $0.64 per share and $12.39 billion in revenue.
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Clorox reported better than expected fiscal fourth-quarter financial results before the markets opened on Monday, due largely to stronger consumer demand.
Over the past few days, more than 1,000 people have died from COVID-19 per day in the United States. At the current pace, the disease will kill 200,000 people by Labor Day, a figure hard to imagine a...
Whether it’s all speculation or day trading, it seems there is no end to seeing major gains in small and micro-cap stocks that have positive announcements around anything to do with testing,...
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more...
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead mRNA vaccine candidate.
MediciNova saw the coronavirus bump on Monday after it said it had entered a worldwide exclusive agreement with BioComo for the rights to develop a SARS-CoV-2 vaccine.
If scientists say anything about arresting the spread of COVID-19, it is to maintain social distance and to wear masks. New research shows that many companies have no plans to ask employees to do so.
Most large cities in Spain recently emerged from a months-long lockdown as the rise in the numbers of confirmed cases and COVID-19 deaths dropped sharply. But now, new cases have started to surge...